February is Hearth Health Month: BioIQ’s Heart Health Panel helps identify increased cardiovascular risks. Learn More

WEBINAR SERIES

 

Health Insights from BioIQ and Industry Leaders

A six-part webinar series exploring the critical healthcare issues facing America and business leaders in 2021.

BioIQ’s Sean Slovenski and Justin Bellante will be talking with industry experts to discuss how to protect workforces and member communities in the coming year and beyond. They will discuss everything from national health policy to COVID19 testing and vaccination strategy and deployment.

On-Demand
Recorded 1.27.21

Part 1: COVID19 Testing, Vaccine, and Health Care Predictions for 2021

How will the private sector and businesses drive vaccinations, much like they have driven COVID-19 testing? What impact on vaccine deployment, and healthcare in general, will happen with the new administration?

Watch this informative discussion with BioIQ CEO Sean Slovenski and Tom Corry, former Senior Advisor to the CMS Administrator.

Tom Corry is an expert on public healthcare issues and has worked on critical initiatives including: The COVID-19 taskforce, Operation Warp Speed, and other vital healthcare policy initiatives.

Coming Soon
2.23.21

Part 2: Technology Innovation is Driving Change for Healthcare Outcomes to Underserved Communities

Today, two of the biggest challenges in healthcare are accessibility and affordability. Nowhere is this more evident than in high-risk, underserved minority health populations, who have been impacted most severely by COVID19.

Eric Dishman, a global leader in health care innovation, will discuss how top tech innovations changes the game for population health and health disparities in the current pandemic and beyond.

Mr. Dishman is the founding Director of the All of Us research program, leading the effort to build the National Institute of Health (NIH) team, consortium, and infrastructure to launch recruitment and data collection nationally. Prior to All of Us, he was an Intel fellow and vice president of the Health and Life Sciences Group at Intel Corporation.